EKTA-B Elekta AB (publ)

6.103USD62.00 SEK · STO-0.80%Mkt Cap: 2.33B USDP/E: —

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machin…

Institutional holders10 on file

Key Statistics

Company
Market Cap2.33B USD
Enterprise Value2.87B USD
Revenue (TTM)1.63B USD
Gross Profit615.09M USD
Net Income (TTM)-51.08M USD
Revenue/Share4.28 USD
Last Price6.103 USD
Fiscal Year EndApr 2026
MR QuarterJul 2026
Employees4.0K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0000163628
Valuation
P/E (Trailing)—
P/E (Forward)12.78
PEG0.43
EV/EBITDA15.83
EV/Revenue1.76
P/S1.43
P/B3.26
EPS (TTM)-0.09 USD
EPS (Forward)0.48 USD
52W Range
4.12081% of range6.565
52W High6.565 USD
52W Low4.120 USD
Profitability
Gross Margin37.38%
Oper. Margin9.22%
EBITDA Margin11.10%
Profit Margin-3.10%
ROE-7.31%
ROA-1.93%
ROIC0.89%
ROCE0.85%
Growth
Revenue Growth-3.00%
Earnings Growth146.40%
Cash Flow & Leverage
Operating CF242.53M USD
CapEx (TTM)105.52M USD
FCF Margin9.82%
FCF Yield6.89%
Net Debt445.39M USD
Net Debt/EBITDA2.45
Net Debt/FCF2.77
Balance Sheet
Debt/Equity1.03
Current Ratio0.86
Quick Ratio0.62
Book Value/Sh1.87 USD
Cash/Share0.57 USD
Dividends
Fwd Div Rate0.24 USD
Trail. Div Rate0.24 USD
Div. Yield3.84%
5Y Avg Yield3.20%
Payout Ratio315.79%
Ex-Div DateMar 4, 2027
Pay Date—
Splits
Last Split4:1
Split DateSep 12, 2012
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)5.812 USD
Upside (mean)-4.8%
Target Range4.036 USD – 8.859 USD
4.036-4.8% to mean8.859
# Analysts15
Ownership
Shares Out.367.10M
Float325.92M
Insiders2.23%
Institutions69.90%
Technical
SMA 505.495 (+11.1%)
SMA 2005.345 (+14.2%)
Beta1.00
S&P 52W Chg12.00%
Avg Vol (30d)1.25M
Avg Vol (10d)1.57M
Technical Indicators
RSI (14)62.0
MACD1.8850
MACD Signal1.9190
MACD Hist.-0.0340
BB Upper6.307 USD
BB Middle5.948 USD
BB Lower5.590 USD
BB Width12.04%
ATR (14)0.1492 USD
Vol Ratio (20d)1.01x

About Elekta (STO: EKTA-B)

›

Elekta (STO: EKTA-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 3,996 employees.

The shares were at 62.00 SEK on 19 November 2026, up 32.5% over 52 weeks. Its 52-week range is 41.86 SEK to 66.70 SEK: the price is 7.0% below the high and 48.1% above the low.

Its market capitalisation is 23.69B SEK. It pays a dividend yielding 3.84%, against a median of 2.36% among the dividend payers in that peer group.

Elekta reports return on equity of -7.3%, an operating margin of 9.2% and revenue down 3.0% year over year.

Its debt exceeds its cash by 4.53B SEK, a debt-to-equity ratio of 1.03. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 15 analysts cover the stock, with an average rating of Hold; their mean price target of 59.05 SEK is 4.8% below the current price. The next earnings report is expected on 25 November 2026.